Recon: Takeda CEO Weber to step down; Merck halts PAH drug trial early on strong efficacy data

ReconReconBiologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States